PL2191828T3 - Przeciwgrzybicza kompozycja farmaceutyczna - Google Patents

Przeciwgrzybicza kompozycja farmaceutyczna

Info

Publication number
PL2191828T3
PL2191828T3 PL08829675T PL08829675T PL2191828T3 PL 2191828 T3 PL2191828 T3 PL 2191828T3 PL 08829675 T PL08829675 T PL 08829675T PL 08829675 T PL08829675 T PL 08829675T PL 2191828 T3 PL2191828 T3 PL 2191828T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
antifungal pharmaceutical
antifungal
composition
pharmaceutical
Prior art date
Application number
PL08829675T
Other languages
English (en)
Inventor
Takaaki Masuda
Naoto Nishida
Naoko Kobayashi
Hideaki Sasagawa
Original Assignee
Pola Pharma Inc.
Nihon Nohyaku Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Pharma Inc., Nihon Nohyaku Co., Ltd. filed Critical Pola Pharma Inc.
Publication of PL2191828T3 publication Critical patent/PL2191828T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
PL08829675T 2007-09-05 2008-09-05 Przeciwgrzybicza kompozycja farmaceutyczna PL2191828T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007229617 2007-09-05

Publications (1)

Publication Number Publication Date
PL2191828T3 true PL2191828T3 (pl) 2017-02-28

Family

ID=40428956

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08829675T PL2191828T3 (pl) 2007-09-05 2008-09-05 Przeciwgrzybicza kompozycja farmaceutyczna

Country Status (9)

Country Link
US (2) US9480678B2 (pl)
EP (1) EP2191828B1 (pl)
JP (1) JP5453093B2 (pl)
KR (1) KR20100068271A (pl)
CN (1) CN101808639B (pl)
ES (1) ES2591030T3 (pl)
HU (1) HUE030028T2 (pl)
PL (1) PL2191828T3 (pl)
WO (1) WO2009031644A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5184342B2 (ja) * 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
ES2421613T3 (es) * 2006-03-08 2013-09-04 Nihon Nohyaku Co Ltd Composición farmacéutica externa
JP5184341B2 (ja) * 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
EP2191826B1 (en) * 2007-09-05 2017-03-08 Pola Pharma Inc. Pharmaceutical composition
EP2191827B1 (en) 2007-09-05 2013-10-30 Pola Pharma Inc. Antifungal composition
HUE030028T2 (en) 2007-09-05 2017-04-28 Pola Pharma Inc Antifungal drug
CN102395274B (zh) * 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
US9050271B2 (en) 2009-04-09 2015-06-09 Pola Pharma Inc. Antimycotic pharmaceutical composition
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
US8952044B2 (en) 2009-08-25 2015-02-10 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2579847A1 (en) 2010-06-11 2013-04-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
CN104619704B (zh) 2012-09-14 2017-12-05 宝丽制药股份有限公司 表面自由能用于分化评价晶体的用途,基于表面自由能作为指标评价的晶体,以及通过包含所述晶体制备的药物组合物
RU2603963C2 (ru) 2012-09-14 2016-12-10 Пола Фарма Инк. Кристалл, обладающий кристаллическими габитусами, и фармацевтическая композиция, полученная обработкой данного кристалла
IN2015DN02929A (pl) 2012-09-14 2015-09-18 Pola Pharma Inc
CN104619320A (zh) 2012-09-14 2015-05-13 宝丽制药股份有限公司 含有卢立康唑的药物组合物
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
US11554108B2 (en) 2016-08-29 2023-01-17 Xeropedix, Inc. Methods and compositions for treating cutaneous fungal infections
EP3503874A1 (en) * 2016-08-29 2019-07-03 Carl F. Schanbacher Methods and compositions for treating cutaneous fungal infections
US10898470B1 (en) * 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
JP7361004B2 (ja) 2020-09-08 2023-10-13 信越化学工業株式会社 アルコール組成物の製造方法

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267169A (en) 1978-07-22 1981-05-12 Toko Yakuhin Kogyo Kabushiki Kaisha Novel preparation of clotrimazole
JPS5815909A (ja) 1981-07-22 1983-01-29 Toko Yakuhin Kogyo Kk 抗真菌外用剤
US4636520A (en) 1984-07-16 1987-01-13 Fujisawa Pharmaceutical Co., Ltd. Antifungal composition employing pyrrolnitrin in combination with an imidazole compound
JPH0236572B2 (ja) 1984-11-13 1990-08-17 Hokuriku Pharmaceutical Suteroidoo177monoesuteruganjukuriimuzai
JPS6293227A (ja) 1985-10-19 1987-04-28 Nippon Nohyaku Co Ltd 抗真菌剤
US4764381A (en) 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
JPH0774144B2 (ja) 1986-03-12 1995-08-09 久光製薬株式会社 尿素を含有する皮膚用組成物
US5686489A (en) 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
JPH0818983B2 (ja) * 1987-12-08 1996-02-28 塩野義製薬株式会社 水虫治療剤
JPH01246219A (ja) 1988-03-25 1989-10-02 Nippon Nohyaku Co Ltd 抗真菌外用クリーム組成物
JPH01242525A (ja) * 1988-03-25 1989-09-27 Nippon Nohyaku Co Ltd 抗真菌外用剤
JP3030780B2 (ja) 1988-12-29 2000-04-10 日本農薬株式会社 光学活性なケテンジチオアセタール誘導体及びその製造方法
JPH02264723A (ja) 1989-04-06 1990-10-29 Taisho Pharmaceut Co Ltd 抗真菌剤
CA2056445A1 (en) 1989-05-26 1990-11-27 Ho-Wah Hui Injectable clarithromycin composition
IL97012A0 (en) 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails
US5403737A (en) * 1990-08-09 1995-04-04 Genentech, Inc. Serine protease variants having peptide ligase activity
US5340836A (en) 1991-02-19 1994-08-23 Mark S. Reinhard Composition and method for treatment of vaginal yeast infections
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
JP2555555B2 (ja) 1991-07-03 1996-11-20 武田薬品工業株式会社 抗真菌性外用製剤
JPH0570351A (ja) 1991-09-17 1993-03-23 Lion Corp 医療用製剤
JPH0665076A (ja) 1992-08-19 1994-03-08 Pola Chem Ind Inc 抗真菌外用剤
JPH06199701A (ja) 1992-12-29 1994-07-19 Lion Corp 外用消炎鎮痛剤
JPH06211651A (ja) 1993-01-12 1994-08-02 Hisamitsu Pharmaceut Co Inc 爪白癬治療用組成物
JPH0774144A (ja) 1993-06-29 1995-03-17 Sony Corp プラズマ装置のクリーニング方法
SK279919B6 (sk) 1993-07-01 1999-05-07 Yamanouchi Europe B.V. Farmaceutický a kozmetický prostriedok na miestne
DE4337945A1 (de) 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
JP2860748B2 (ja) 1993-12-24 1999-02-24 エスエス製薬株式会社 安定な酪酸ヒドロコルチゾン含有クリーム剤
JP3803393B2 (ja) 1994-01-12 2006-08-02 久光製薬株式会社 爪白癬治療用組成物
JP3629283B2 (ja) 1994-02-15 2005-03-16 ポーラ化成工業株式会社 皮膚外用剤
JP3081766B2 (ja) 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
JP3522832B2 (ja) 1994-06-21 2004-04-26 ポーラ化成工業株式会社 経皮吸収促進剤及び皮膚外用剤
GB9420355D0 (en) 1994-10-10 1994-11-23 Univ Nottingham Preparation of protein microspheres, films and coatings
WO1996011710A1 (fr) * 1994-10-13 1996-04-25 Hisamitsu Pharmaceutical Co., Inc. Preparation externe pour onychomycose
SE9502244D0 (sv) 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
JP3278738B2 (ja) 1995-07-08 2002-04-30 日本農薬株式会社 抗真菌剤
US5900488A (en) 1995-07-08 1999-05-04 Nihon Nohyaku Co., Ltd. Method for treating mycosis using imidazolylacetonitrile derivatives
US6008256A (en) 1995-08-28 1999-12-28 Showa Yakuhin Kako Co., Ltd. Composition for local anesthesia
US5993787A (en) 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
JP4253047B2 (ja) 1996-09-27 2009-04-08 杏林製薬株式会社 被膜形成性抗真菌剤組成物
JPH10226686A (ja) 1996-12-10 1998-08-25 Nippon Nohyaku Co Ltd 光学活性体である(r)−(e)−(4−置換フェニル−1,3−ジチオラン−2−イリデン)−1−イミダゾールアセトニトリル誘導体及び抗真菌剤及びそれらの製造方法
JP4227677B2 (ja) 1996-12-10 2009-02-18 杏林製薬株式会社 被膜形成性抗真菌剤組成物
EP0973768B1 (en) * 1997-03-31 2003-07-09 Takeda Chemical Industries, Ltd. Azole compounds, their production and their use
WO2000001384A1 (fr) 1998-07-01 2000-01-13 Lead Chemical Co., Ltd. Preparation a base de ketotifene destinee a etre absorbee par voie percutanee
US5962536A (en) 1998-07-31 1999-10-05 Komer; Gene Injectable propofol formulations
CA2343284C (en) 1998-09-10 2008-11-18 Ipr-Institute For Pharmaceutical Research Ag Topical application products
JP2000169372A (ja) 1998-09-29 2000-06-20 Takeda Chem Ind Ltd 抗真菌薬組成物
US20040208906A1 (en) 1999-07-12 2004-10-21 Daiichi Suntory Pharma Co., Ltd. Pharmaceutical composition for topical administration
JP2001064206A (ja) 1999-08-30 2001-03-13 Isp Japan Kk 経皮吸収促進組成物
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US6428654B1 (en) 2000-04-05 2002-08-06 Hercules Incorporated Fungicidal method
JP2002114680A (ja) 2000-07-31 2002-04-16 Nippon Nohyaku Co Ltd 抗真菌剤
JP2002193755A (ja) * 2000-12-28 2002-07-10 Sansho Seiyaku Co Ltd フケ・カユミ防止頭髪用および洗髪用化粧料
JP2002284702A (ja) 2001-01-19 2002-10-03 Teika Seiyaku Kk 外用抗真菌製剤
KR100423666B1 (ko) 2001-02-07 2004-03-18 보령제약 주식회사 항진균 외용 제제
US6585963B1 (en) 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US20030017207A1 (en) 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
JP2002363070A (ja) 2001-06-06 2002-12-18 Yuutoku Yakuhin Kogyo Kk 経皮吸収貼付剤
CZ2004315A3 (cs) 2001-09-04 2004-10-13 Trommsdorffágmbhá@Áco@Ákgáarzneimittel Náplast
JP2003252798A (ja) 2002-02-28 2003-09-10 Shiseido Co Ltd 抗菌ゲル製剤
JPWO2003105841A1 (ja) 2002-06-18 2005-10-13 ポーラ化成工業株式会社 抗真菌医薬組成物
US6846837B2 (en) 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails
JP4387639B2 (ja) 2002-07-16 2009-12-16 久光製薬株式会社 経皮吸収製剤
EP1545619B1 (en) 2002-09-05 2008-01-23 Galderma S.A. Solution for ungual application
WO2004037225A2 (en) 2002-10-25 2004-05-06 Foamix Ltd. Cosmetic and pharmaceutical foam
US7462362B2 (en) 2003-03-21 2008-12-09 Nexmed Holdings, Inc. Antifungal nail coat and method of use
WO2004091521A2 (en) 2003-04-10 2004-10-28 Neurogesx, Inc. Methods and compositions for administration of trpv1 agonists
WO2005000287A1 (ja) 2003-06-25 2005-01-06 Hisamitsu Pharmaceutical Co., Inc. 水虫治療用外用剤
JP2005104924A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 外用医薬組成物
JP4431369B2 (ja) 2003-11-21 2010-03-10 久光製薬株式会社 抗真菌エアゾール外用製剤
JP2005203536A (ja) * 2004-01-15 2005-07-28 Matsushita Electric Ind Co Ltd 光送信器
WO2005079573A1 (en) * 2004-02-24 2005-09-01 Givaudan Sa Antifungal compositions
JP4429035B2 (ja) 2004-02-27 2010-03-10 久光製薬株式会社 角質貯留性を高めた外用クリーム製剤
JP3783104B2 (ja) 2004-03-31 2006-06-07 小林製薬株式会社 抗真菌性外用組成物
US7928144B2 (en) 2004-06-15 2011-04-19 Hisamitsu Pharmaceutical Co., Inc. Antiinflammatory and analgesic preparation for external use
JP4690672B2 (ja) 2004-07-20 2011-06-01 岩城製薬株式会社 乳剤性皮膚外用剤
JP3800232B2 (ja) 2004-09-30 2006-07-26 小林製薬株式会社 抗真菌性外用組成物
JP2006306734A (ja) 2005-04-26 2006-11-09 Tsumura & Co 尿素配合外用剤
CN101351227A (zh) 2005-12-28 2009-01-21 帝国制药株式会社 指甲用医药组合物
JP5184341B2 (ja) 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
JP5184342B2 (ja) 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
ES2421613T3 (es) 2006-03-08 2013-09-04 Nihon Nohyaku Co Ltd Composición farmacéutica externa
WO2008075207A2 (en) 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
EP2191826B1 (en) 2007-09-05 2017-03-08 Pola Pharma Inc. Pharmaceutical composition
HUE030028T2 (en) 2007-09-05 2017-04-28 Pola Pharma Inc Antifungal drug
EP2191827B1 (en) 2007-09-05 2013-10-30 Pola Pharma Inc. Antifungal composition
CN102395274B (zh) 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
US9050271B2 (en) 2009-04-09 2015-06-09 Pola Pharma Inc. Antimycotic pharmaceutical composition
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition

Also Published As

Publication number Publication date
ES2591030T3 (es) 2016-11-24
CN101808639A (zh) 2010-08-18
US9480678B2 (en) 2016-11-01
JPWO2009031644A1 (ja) 2010-12-16
CN101808639B (zh) 2012-12-05
KR20100068271A (ko) 2010-06-22
EP2191828A4 (en) 2010-09-15
US20160361299A1 (en) 2016-12-15
EP2191828A1 (en) 2010-06-02
JP5453093B2 (ja) 2014-03-26
HUE030028T2 (en) 2017-04-28
EP2191828B1 (en) 2016-08-10
US20100168200A1 (en) 2010-07-01
WO2009031644A1 (ja) 2009-03-12

Similar Documents

Publication Publication Date Title
HUS1800007I1 (hu) Gyógyászati készítmény
PL2191828T3 (pl) Przeciwgrzybicza kompozycja farmaceutyczna
EP2133095A4 (en) PHARMACEUTICAL COMPOSITION
EP2133094A4 (en) PHARMACEUTICAL COMPOSITION
EP2191827A4 (en) ANTIMYCOTIC COMPOSITION
EP2191826A4 (en) PHARMACEUTICAL COMPOSITION
HK1136968A1 (en) Novel pharmaceutical composition
IL200125A0 (en) Pharmaceutical composition
EP2116242A4 (en) NEW PHARMACEUTICAL COMPOSITION
EP2224805A4 (en) PHARMACEUTICAL COMPOSITION
EP2224915A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2206430A4 (en) ANTIMYCOTIC COMPOSITION
GB0712389D0 (en) A Pharmaceutical composition
EP2268278A4 (en) PHARMACEUTICAL COMPOSITION
HK1138774A1 (en) Pharmaceutical composition
EP2224808A4 (en) PHARMACEUTICAL COMPOSITION
EP2156832A4 (en) PHARMACEUTICAL COMPOSITION
HK1141742A1 (en) Antifungal composition
EP2224806A4 (en) PHARMACEUTICAL COMPOSITION
IL205975A0 (en) Pharmaceutical composition
GB0818725D0 (en) Pharmaceutical composition
GB0817969D0 (en) Pharmaceutical composition
IL205931A0 (en) Pharmaceutical composition
EP2204173A4 (en) PHARMACEUTICAL COMPOSITION HAVING ANTIDIABETIC EFFECT
GB0717036D0 (en) Pharmaceutical composition